Pharmaceutical tablet
Latest Solvay Pharmaceuticals B.V. Patents:
- 1H-imidazole derivative having CB, agonistic, CBpartial agonistic or CBantagnistic activity
- Sulphur containing pyrazole derivatives as selective cannabinoid CB receptor antagonists
- 4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CBreceptor modulators
- Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
- Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof
Description
Claims
I claim the ornamental design for a pharmaceutical tablet, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
1836604 | December 1931 | Meyer |
D183846 | November 1958 | Lippert |
4215104 | July 29, 1980 | Ullman et al. |
4353887 | October 12, 1982 | Hess et al. |
D283739 | May 6, 1986 | Tovey |
D310579 | September 11, 1990 | Ni et al. |
5009896 | April 23, 1991 | Becker |
5061494 | October 29, 1991 | Ni et al. |
D331280 | November 24, 1992 | Tovey |
D346442 | April 26, 1994 | Kramer et al. |
D361615 | August 22, 1995 | Tovey |
D361837 | August 29, 1995 | Swinkels |
D372082 | July 23, 1996 | Sauer |
D375549 | November 12, 1996 | Sauer |
D383533 | September 9, 1997 | Jushchyshyn et al. |
D383534 | September 9, 1997 | Jushchyshyn et al. |
D434492 | November 28, 2000 | Holland et al. |
D439654 | March 27, 2001 | Hite et al. |
D459798 | July 2, 2002 | Desesquelle et al. |
- US Trademark Registration No. 1589683, registered Apr. 3, 1990.
- US Trademark Registration No. 1593778, registered May 1, 1990.
- US Trademark Registration No. 2062395, registered May 13, 1997.
- US Trademark Registration No. 2225909, registered Feb. 23, 1999.
- US Trademark Registration No. 2455628, registered May 29, 2001.
Patent History
Patent number: D589606
Type: Grant
Filed: Jun 3, 2008
Date of Patent: Mar 31, 2009
Assignee: Solvay Pharmaceuticals B.V. (Weesp)
Inventor: Gerrit Schonewille (Almere)
Primary Examiner: Charles A Rademaker
Attorney: Novak Druce + Quigg LLP
Application Number: 29/319,091
Type: Grant
Filed: Jun 3, 2008
Date of Patent: Mar 31, 2009
Assignee: Solvay Pharmaceuticals B.V. (Weesp)
Inventor: Gerrit Schonewille (Almere)
Primary Examiner: Charles A Rademaker
Attorney: Novak Druce + Quigg LLP
Application Number: 29/319,091
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101)